Close Menu

NEW YORK – PerkinElmer said after the close of the market on Tuesday that its revenues for the second quarter increased a fraction of 1 percent year over year, while its Diagnostics segment slipped 2 percent.

For the three months ended April 5, the Waltham, Massachusetts-based company posted total revenues of $652.4 million compared to $648.7 million a year ago, and slightly below the consensus Wall Street estimate of $652.7 million. Organic revenues were down about 1 percent, PerkinElmer said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.